Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study.
Allegrini A, Nuzzo L, Pavone D, Tavella-Scaringi A, Giangreco D, Bucci M, Toniato E, Mezzetti A, Martinotti S, Comuzio S, Di Grigoli M, Bonani S. Allegrini A, et al. Among authors: bucci m. Arzneimittelforschung. 2009;59(8):403-9. doi: 10.1055/s-0031-1296415. Arzneimittelforschung. 2009. PMID: 19813463 Clinical Trial.
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, Fazia M, Iezzi A, Cuccurullo C, Pini B, Bucci M, Santucci A, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: bucci m. Circulation. 2003 Dec 2;108(22):2776-82. doi: 10.1161/01.CIR.0000103700.05109.0D. Epub 2003 Nov 17. Circulation. 2003. PMID: 14623801 Clinical Trial.
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: bucci m. Circulation. 2004 Mar 30;109(12):1482-8. doi: 10.1161/01.CIR.0000121735.52471.AC. Epub 2004 Mar 22. Circulation. 2004. PMID: 15037537 Clinical Trial.
Association between 5-lipoxygenase expression and plaque instability in humans.
Cipollone F, Mezzetti A, Fazia ML, Cuccurullo C, Iezzi A, Ucchino S, Spigonardo F, Bucci M, Cuccurullo F, Prescott SM, Stafforini DM. Cipollone F, et al. Among authors: bucci m. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1665-70. doi: 10.1161/01.ATV.0000172632.96987.2d. Epub 2005 Jun 2. Arterioscler Thromb Vasc Biol. 2005. PMID: 15933245
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers.
Allegrini A, Nuzzo L, Zucchelli M, Tavella-Scaringi A, Bucci M, Pavone D, Toniato E, Mezzetti A, Martinotti S, Bonani S. Allegrini A, et al. Among authors: bucci m. Arzneimittelforschung. 2009;59(8):392-6. doi: 10.1055/s-0031-1296413. Arzneimittelforschung. 2009. PMID: 19813461 Clinical Trial.
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.
Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, Magnacca F, Ucchino S, Mastroiacovo D, Desideri G, Mezzetti A, Cipollone F. Santovito D, et al. Among authors: bucci m. Expert Opin Ther Targets. 2013 Mar;17(3):217-23. doi: 10.1517/14728222.2013.745512. Epub 2013 Jan 23. Expert Opin Ther Targets. 2013. PMID: 23339529
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial.
Cicolini G, Simonetti V, Comparcini D, Celiberti I, Di Nicola M, Capasso LM, Flacco ME, Bucci M, Mezzetti A, Manzoli L. Cicolini G, et al. Among authors: bucci m. Int J Nurs Stud. 2014 Jun;51(6):833-43. doi: 10.1016/j.ijnurstu.2013.10.010. Epub 2013 Oct 25. Int J Nurs Stud. 2014. PMID: 24225325 Clinical Trial.
754 results